Palantir's commercial penetration spans 7+ industry verticals with varying maturity. Healthcare is the most publicly documented vertical, powering >15% of the US healthcare system with named deployments at HCA, Cleveland Clinic, Tampa General, Mt. Sinai, and others, generating quantifiable ROI ($6M nursing savings at HCA, 28% PACU hold time reduction at Tampa General). Energy is a decade-deep vertical — BP processes 1 billion data points/day through Foundry, PG&E achieved a 99% reduction in acres burned via wildfire prediction across 25,000 miles of lines.
Average US commercial revenue per customer is ~$2.6M annualized (FY2025: $1,465M / 571 customers), but top-20 customers average $93.9M, indicating massive expansion potential within existing accounts. The industry-specific TAM math suggests healthcare AI ($50-70B by 2030), financial services AI ($40-60B), manufacturing AI ($30-50B), and energy AI ($15-25B) represent $135-205B of addressable market — of which Palantir likely needs only 3-5% share to justify the platform premium.
| Microsoft | Healthcare AI faces severe regulatory and adoption barriers: 82% of AI implementations encounter HIPAA-related barriers around data de-identification and consent. Only 18% of healthcare organizatio... |
| AWS | Enterprise AI spending is entering a vendor consolidation and rationalization phase: enterprises are cutting experimentation budgets, rationalizing overlapping tools, and coalescing around a shortl... |
| Anduril | Warp Speed manufacturing OS launched Dec 2024 with inaugural cohort: Anduril, L3Harris, Panasonic Energy (PENA), Shield AI. Second cohort (Mar 2025): Epirus, Red Cat, Saildrone, Saronic, Ursa Major... |
| L3Harris | Warp Speed manufacturing OS launched Dec 2024 with inaugural cohort: Anduril, L3Harris, Panasonic Energy (PENA), Shield AI. Second cohort (Mar 2025): Epirus, Red Cat, Saildrone, Saronic, Ursa Major... |
Key Risk
RAND Corporation finds 80.3% of enterprise AI projects fail: 33.8% abandoned before production, 28.4% complete but deliver no value, 18.1% deliver some value but cannot justify costs. Only 19.7% achieve or exceed objectives. MIT Sloan (Jul 2025) finds 95% of GenAI pilots deliver no measurable P&L im
What is the revenue breakdown by industry vertical? Palantir does not disclose this in filings — only government vs. commercial vs. international splits.